Clinical Trials Browser

Phase 1/2 × Desmoid Tumors × Imatinib Mesylate × Clear all

NCT00287846 2016-08-30

Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis

Phase 1/2 Completed

Desmoid Tumors